U.S. Physical Therapy Logo
US90337L1089
923954
USPH

U.S. Physical Therapy

Caricamento quotazioni...

Previsioni

Il prezzo obiettivo medio degli analisti è 81,09 € (-10,15%). La mediana è 81,09 € (-10,15%).

Acquista
  10
Mantieni
  3
Vendi
  0

Discussioni nella community

Non ci sono ancora discussioni su questo asset.

Avvia discussione

  • U.S. Physical Therapy expands hospital alliances with NYU Langone to boost visits and reimbursement

    U.S. Physical Therapy is pursuing growth through clinic openings, acquisitions and hospital alliances, highlighted by a 10-year NYU Langone partnership that added 60 New York locations and yields flat per-visit payments with higher, more predictable reimbursement. The company opens about 25–30 clinics organically and acquires 30–70 annually using a local-partnership model that preserves clinician ownership and brands. Its injury-prevention unit has grown to roughly $120 million in revenue and more than $20 million in EBITDA, delivering margins about twice those of the physical therapy segment. Management reports about $220 million in debt, expects EBITDA above $100 million for the year, and has capital available for further expansion and share repurchases. » Altro su finance.yahoo.com


  • U.S. Physical Therapy relies on partnerships and Briotix to offset Medicare pressure

    U.S. Physical Therapy pursues a growth strategy based on a partnership model, hospital alliances (including an exclusive deal with NYU Langone) and expansion of its Briotix division to compensate for lower Medicare reimbursements and competition in the outpatient market. The NYU partnership is expected to bring about 700,000 additional treatments per year long term; Briotix generates roughly $120 million in revenue with substantially higher margins than the physical therapy business. Management views debt of about $220 million and expected EBITDA above $100 million as a manageable framework; it anticipates recoveries in Medicare reimbursement from 2024/2025 and stronger increases from 2028. » Altro su de.investing.com


  • Nchacha Etta to become CFO of U.S. Physical Therapy

    U.S. Physical Therapy appoints Nchacha Etta effective September 1, 2026, as executive vice president and chief financial officer. Etta previously served as CFO at Omnicell and held financial leadership roles at Essilor of America, Johnson & Johnson Vision and Coca‑Cola; he also sits on the board of directors of KBR. Jason Curtis will remain senior vice president for finance and accounting and will return to that role after serving as interim CFO. U.S. Physical Therapy operates 796 outpatient physical therapy clinics in 45 U.S. states. » Altro su de.investing.com


  • U.S. Physical Therapy expands into new U.S. state through acquisition

    U.S. Physical Therapy has acquired a physiotherapy group with 12 clinics, taking a 67% stake in the company while the previous owners retain 33%. The acquired group delivers about 112,000 treatments per year and generates annual revenue of USD 12 million. With the purchase, U.S. Physical Therapy increases its presence from 44 to 45 states and now operates 795 outpatient clinics; trailing twelve‑month revenue is USD 788 million. » Altro su de.investing.com


  • U.S. Physical Therapy misses Q1 2026 forecasts, stock falls

    U.S. Physical Therapy reported a GAAP loss per share of $0.12 for Q1 2026, missing the expected $0.54 by a wide margin; revenue was $198 million (expectation $200.26 million), a year‑over‑year increase of 7.9%. Weather‑related cancellations of roughly 31,000 patient appointments are estimated to have reduced revenue by about $3.3 million. The stock fell roughly 2% in after‑hours trading; management plans to push efficiency measures, virtualize reception areas, implement AI‑assisted documentation, and expand self‑pay offerings. » Altro su de.investing.com

Nel 2026, U.S. Physical Therapy ha già distribuito 1,19 € di dividendi. L'ultimo pagamento è avvenuto a settembre.

Dati finanziari dell'azienda

Nell'ultimo trimestre, U.S. Physical Therapy ha registrato ricavi pari a 196,49 Mln € e un utile netto di 9,75 Mln €
(EUR) settembre 2026
YoY
Ricavi 196,49 Mln 40,58%
Utile lordo 37,99 Mln 20,91%
Utile netto 9,75 Mln 57,99%
EBITDA 27,71 Mln 4,52%

Dati fondamentali

Metrica Valore
Capitalizzazione di mercato
1,33 Mld €
Numero di azioni
14,93 Mln
Massimo/minimo a 52 settimane
91,16 € - 52,43 €
Rendimento da dividendo
1,74%
Dividendi TTM
1,57 €
Prossimo dividendo
0,41 €
Beta
1,13
Rapporto P/E
-73,51
Rapporto PEG
0,47
Rapporto P/B
3,45
Rapporto P/S
1,77

Profilo aziendale

U.S. Physical Therapy, Inc., attraverso le sue controllate, gestisce cliniche ambulatoriali di fisioterapia che offrono assistenza e trattamenti pre e post-operatori per disturbi ortopedici, infortuni legati allo sport, cure preventive, riabilitazione di lavoratori infortunati e lesioni di natura neurologica. Opera attraverso due segmenti, Physical Therapy Operations e Industrial Injury Prevention Services. L'azienda offre servizi di prevenzione degli infortuni sul lavoro, tra cui prevenzione e riabilitazione in loco, ottimizzazione delle prestazioni, test occupazionali post-offerta, valutazioni della capacità funzionale e valutazioni ergonomiche, tramite fisioterapisti e preparatori atletici certificati specializzati, per aziende Fortune 500 e altri clienti, tra cui assicuratori e loro appaltatori. Al 31 dicembre 2021 gestiva 591 cliniche in 39 stati e amministrava 35 strutture di studi di fisioterapia. La società è stata fondata nel 1990 ed ha sede a Houston, Texas.

Nome
U.S. Physical Therapy
CEO
Christopher J. Reading
Sede centrale Houston, tx
Stati Uniti
Sito web
Settore
SanitĂ 
Industria
Fornitori e servizi sanitari
Quotazione in borsa
29/05/1992
Dipendenti 6374

Simboli di borsa

Borsa Simbolo
NYSE
USPH
Frankfurt
UPH.F
DĂĽsseldorf
UPH.DU
🍪

Parqet  usa i cookie. Scopri di più